Board of Directors Bios

César M. García, Chairman of the Board. Mr. García was appointed Chairman in November, 2007 and has been a member of the Board of Directors since November 2003. He joined the company in January 2002 as Executive Vice President and was appointed President in June 2003 and Chief Executive Officer and a director in November 2003. Mr. García has over 30 years of experience in medical device manufacturing. Prior to joining IRIS, Mr. García was Sr. Vice President, Operations and Program Management for Cytometrics Inc., an early stage manufacturer of non-invasive medical devices for hematology and cytology. From 1994 to 1998, he was Vice President of Operations and Engineering at Datascope Corp., which manufactures medical devices for interventional cardiology, anesthesiology and critical care monitoring. From 1974 to 1994, Mr. García worked with Bayer assuming positions of increased responsibility including General Manager of Technicon Electronics Corp., a subsidiary of Bayer USA, and Director of Worldwide Hematology Manufacturing and Cellular Diagnostics Research and Development. Mr. García earned his B.S. in Industrial Engineering (Cum Laude) at the University of Puerto Rico and received an Advanced Management Certificate from Pace University.

Richard H. Williams, Lead Director. Mr. Williams was appointed Chairman in February, 2004 and has been a member of the Board of Directors since June 2003. An experienced businessman and entrepreneur, has served as a consultant to many emerging growth companies since 1980. He has founded and helped structure, finance and take public a number of small public and private companies. Among them, InTime Systems International, a software company, Telcom Services, Inc. & Restor Industries, Inc., both companies involved in the telecommunications market, and A&W Exploration Corporation, an operating oil and gas company. Mr. Williams has been Chairman and CEO of several of these companies. Before becoming an entrepreneur in 1980, Mr. Williams was Vice President of a $100 million consumer products division of Pfizer, Inc. Most recently, he served as Chairman of Williams Resource Group, his own company specializing in financial evaluations, personal investment and consulting to emerging growth companies.

Thomas H. Adams, Ph.D.. Dr. Adams was appointed a director in June 2005 and joined IRIS as Corporate Vice President and Chief Technology Officer in April 2006 when the Company acquired Leucadia Technologies, a privately held medical-device company which he founded in 1998. Dr. Adams served as Chairman and Chief Executive Officer of Leucadia Technologies. In 1989 Dr. Adams founded Genta, Inc., a publicly held biotechnology company in the field of antisense technology, and served as its Chief Executive Officer until 1997. Dr. Adams founded Gen-Probe, Inc. in 1984 and served as its Chief Executive Officer and Chairman until 1989. Before founding Gen-Probe, Dr. Adams was CTO of Hybritech Inc. and has also held management positions at Technicon Instruments and the Hyland Division of Baxter. He served as a director of Biosite Diagnostics, Inc. from 1989 to 1998 and as a director of Invitrogen from 2000 to 2002. Dr. Adams currently serves as a director of La Jolla Pharmaceutical Co. and the privately held company, XiFin, Inc. Dr. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside.

Steven M. Besbeck. Mr. Besbeck has served as a director since 1990. Mr. Besbeck is a private investor and has served on a number of private and public boards of directors. From 1983 to 2007 he was a founder, director, President and Chief Executive Officer of ASPYRA, Inc., a provider of clinical and diagnostic information systems for laboratory, pharmacy and medical imaging departments in hospitals, clinics and other healthcare providers. From 1975 to 1983, Mr. Besbeck was a director, President and Chief Executive Officer of American Cytogenetics, Inc., a provider of specialty clinical laboratory services. Mr. Besbeck holds a B.S. in Finance from California State University, Long Beach.

Michael D. Matte. Mr. Matte was appointed a director in January 2004. Mr. Matte most recently served as Chief Financial Officer of Cyberguard Corporation from 2001 to 2006. From 1981 to 1992, he was employed by Price Waterhouse as a senior audit manager. From 1992 to 1998, he served as Chief Financial Officer for InTime Systems International, and from 1998 to 2001, he served as Chief Financial Officer for AmeriJet International. Mr. Matte is a Certified Public Accountant and holds a B.S. in Accounting from Florida State University.

Richard G. Nadeau, Ph.D.. Dr. Nadeau was appointed a director in January 1999. He is Founder and Chairman of Vistair Ventures, a company he founded in 1984 that funds small businesses, primarily in the high technology fields. Concurrently, Dr. Nadeau held senior positions with various IVD equipment companies, including Chairman and Chief Executive Officer of Cytometrics, Inc., President and Chief Executive Officer of EM Diagnostic Systems, Inc., Senior Vice President and Chief Technical Officer of Technicon Instrument Corporation, President of the Diagnostics Division (North America) of Technicon Instrument Corporation, President of Ortho Diagnostics, Inc., a subsidiary of Johnson & Johnson, Inc., and Worldwide Marketing Manager for the Automatic Clinical Analysis Division of E.I. DuPont de Nemours & Co. He currently serves on the Board of Directors for the Advanced Medical Technology Association. Dr. Nadeau is a former President of the National Committee for Clinical Laboratory Standards and a former Board Member of the European Committee for Clinical Laboratory Standards. Dr. Nadeau is a Fellow in the National Academy of Clinical Biochemistry. He earned his B.S. in pre-Med and M.S. in Biochemistry at the University of New Hampshire and his Ph.D. in Biochemistry at West Virginia University.

Stephen E. Wasserman. Mr. Wasserman was appointed a director in April 2006. Mr. Wasserman was most recently Group Vice President-Diagnostic Systems Products of Olympus America Inc., the U.S. business center for Tokyo-based Olympus Corporation. Mr. Wasserman, who joined Olympus in 1997, directed the North American operations for the Company's In Vitro Diagnostics product business based in Melville, N.Y. Prior to Olympus, from 1994-1997 Mr. Wasserman was Chief Financial Officer of Datascope Corp. and President of its Patient Monitoring Division. From 1989 to 1993, he served as Vice President of NY Blood Center, Inc. and General Manager of its Melville Biologics, Inc. division, a manufacturer, marketer and developer of biopharmaceutical products. Mr. Wasserman previously held key positions from 1981-1989 with Technicon Instruments Corp. (now Bayer Diagnostics), serving as Vice President, General Manager, North America and Vice President and Controller. Mr. Wasserman is a Certified Public Accountant and received a BBA from City College of New York, Baruch School of Business.